ATE534035T1 - Qualitätstests für antigenpräsentierende zellen - Google Patents
Qualitätstests für antigenpräsentierende zellenInfo
- Publication number
- ATE534035T1 ATE534035T1 AT03724535T AT03724535T ATE534035T1 AT E534035 T1 ATE534035 T1 AT E534035T1 AT 03724535 T AT03724535 T AT 03724535T AT 03724535 T AT03724535 T AT 03724535T AT E534035 T1 ATE534035 T1 AT E534035T1
- Authority
- AT
- Austria
- Prior art keywords
- antigen
- presenting cells
- quality tests
- cells
- quality
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37912602P | 2002-05-08 | 2002-05-08 | |
PCT/US2003/014614 WO2003095668A1 (en) | 2002-05-08 | 2003-05-08 | Quality assays for antigen presenting cells |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE534035T1 true ATE534035T1 (de) | 2011-12-15 |
Family
ID=29420489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03724535T ATE534035T1 (de) | 2002-05-08 | 2003-05-08 | Qualitätstests für antigenpräsentierende zellen |
Country Status (15)
Country | Link |
---|---|
US (4) | US20060234309A1 (de) |
EP (2) | EP2290368B1 (de) |
JP (1) | JP2005524412A (de) |
KR (1) | KR20120004544A (de) |
CN (1) | CN1659285A (de) |
AT (1) | ATE534035T1 (de) |
AU (1) | AU2003230366A1 (de) |
BR (1) | BR0309850A (de) |
CA (1) | CA2484743A1 (de) |
HK (1) | HK1154940A1 (de) |
IL (1) | IL165031A0 (de) |
MX (1) | MXPA04011071A (de) |
NZ (1) | NZ536339A (de) |
PL (1) | PL373119A1 (de) |
WO (1) | WO2003095668A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2155782A2 (de) | 2007-03-26 | 2010-02-24 | Dako Denmark A/S | Mhc-peptid-komplexe und anwendungen davon bei infektionskrankheiten |
EP2167537A2 (de) | 2007-07-03 | 2010-03-31 | Dako Denmark A/S | Zusammengestellte verfahren für die analyse und sortierung von proben |
EP2197908A2 (de) | 2007-09-27 | 2010-06-23 | Dako Denmark A/S | Mhc-multimere in tuberkulose-diagnostika, -impfstoff und therapeutika |
US10968269B1 (en) | 2008-02-28 | 2021-04-06 | Agilent Technologies, Inc. | MHC multimers in borrelia diagnostics and disease |
WO2010009735A2 (en) * | 2008-07-23 | 2010-01-28 | Dako Denmark A/S | Combinatorial analysis and repair |
GB0817244D0 (en) | 2008-09-20 | 2008-10-29 | Univ Cardiff | Use of a protein kinase inhibitor to detect immune cells, such as T cells |
WO2010037402A1 (en) | 2008-10-02 | 2010-04-08 | Dako Denmark A/S | Molecular vaccines for infectious disease |
US11992518B2 (en) | 2008-10-02 | 2024-05-28 | Agilent Technologies, Inc. | Molecular vaccines for infectious disease |
US9393418B2 (en) | 2011-06-03 | 2016-07-19 | Great Lakes Neuro Technologies Inc. | Movement disorder therapy system, devices and methods of tuning |
DE102010037622B4 (de) * | 2010-09-17 | 2012-07-12 | Lophius Biosciences Gmbh | Verfahren zum Nachweis, Differenzieren und Quantifizieren von T-Zellpopulationen mittels der Reverse Transkription quantitativen Real-Time PCR (RT-qPCR) Technologie |
CN103869082B (zh) * | 2014-03-18 | 2016-02-03 | 浙江大学 | 免疫荧光法检测hla-dr表达量评估pbmc抗原呈递能力的方法 |
EP3478818A2 (de) | 2016-06-29 | 2019-05-08 | Northeastern University | Zellkulturkammern und verfahren zur verwendung davon |
CA3046827A1 (en) | 2016-12-12 | 2018-06-21 | xCella Biosciences, Inc. | Methods and systems for screening using microcapillary arrays |
MX2021012303A (es) * | 2019-04-08 | 2022-02-21 | Xcella Biosciences Inc | Metodos y sistemas de deteccion usando matrices microcapilares. |
CN110223729B (zh) * | 2019-06-11 | 2023-04-07 | 上海科技大学 | 一种简易高效的肿瘤免疫治疗生物标志物及其用途 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
GB8822228D0 (en) | 1988-09-21 | 1988-10-26 | Southern E M | Support-bound oligonucleotides |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
US5242974A (en) | 1991-11-22 | 1993-09-07 | Affymax Technologies N.V. | Polymer reversal on solid surfaces |
US5527681A (en) | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
DE3924454A1 (de) | 1989-07-24 | 1991-02-07 | Cornelis P Prof Dr Hollenberg | Die anwendung von dna und dna-technologie fuer die konstruktion von netzwerken zur verwendung in der chip-konstruktion und chip-produktion (dna chips) |
IL103674A0 (en) | 1991-11-19 | 1993-04-04 | Houston Advanced Res Center | Method and apparatus for molecule detection |
US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
US5412087A (en) | 1992-04-24 | 1995-05-02 | Affymax Technologies N.V. | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
DK0633929T3 (da) | 1992-04-01 | 2004-06-28 | Univ Rockefeller | Fremgangsmåde til in vitro proliferation af dendritcelleforstadier og deres anvendelse til at producere immunogener |
US5554501A (en) | 1992-10-29 | 1996-09-10 | Beckman Instruments, Inc. | Biopolymer synthesis using surface activated biaxially oriented polypropylene |
US5472672A (en) | 1993-10-22 | 1995-12-05 | The Board Of Trustees Of The Leland Stanford Junior University | Apparatus and method for polymer synthesis using arrays |
US5429807A (en) | 1993-10-28 | 1995-07-04 | Beckman Instruments, Inc. | Method and apparatus for creating biopolymer arrays on a solid support surface |
US5571639A (en) | 1994-05-24 | 1996-11-05 | Affymax Technologies N.V. | Computer-aided engineering system for design of sequence arrays and lithographic masks |
US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
US5599695A (en) | 1995-02-27 | 1997-02-04 | Affymetrix, Inc. | Printing molecular library arrays using deprotection agents solely in the vapor phase |
US5624711A (en) | 1995-04-27 | 1997-04-29 | Affymax Technologies, N.V. | Derivatization of solid supports and methods for oligomer synthesis |
US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
US5658734A (en) | 1995-10-17 | 1997-08-19 | International Business Machines Corporation | Process for synthesizing chemical compounds |
US6150508A (en) | 1996-03-25 | 2000-11-21 | Northwest Biotherapeutics, Inc. | Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
EP1360290A2 (de) * | 2000-06-23 | 2003-11-12 | Maxygen, Inc. | Costimulierende moleküle |
-
2003
- 2003-05-08 CA CA002484743A patent/CA2484743A1/en not_active Abandoned
- 2003-05-08 EP EP10184386A patent/EP2290368B1/de not_active Expired - Lifetime
- 2003-05-08 CN CN038127113A patent/CN1659285A/zh active Pending
- 2003-05-08 JP JP2004503658A patent/JP2005524412A/ja active Pending
- 2003-05-08 AT AT03724535T patent/ATE534035T1/de active
- 2003-05-08 PL PL03373119A patent/PL373119A1/xx not_active Application Discontinuation
- 2003-05-08 KR KR1020117028751A patent/KR20120004544A/ko not_active Application Discontinuation
- 2003-05-08 US US10/513,847 patent/US20060234309A1/en not_active Abandoned
- 2003-05-08 WO PCT/US2003/014614 patent/WO2003095668A1/en active Application Filing
- 2003-05-08 EP EP03724535A patent/EP1507868B1/de not_active Expired - Lifetime
- 2003-05-08 MX MXPA04011071A patent/MXPA04011071A/es not_active Application Discontinuation
- 2003-05-08 BR BR0309850-8A patent/BR0309850A/pt not_active IP Right Cessation
- 2003-05-08 NZ NZ536339A patent/NZ536339A/en not_active IP Right Cessation
- 2003-05-08 AU AU2003230366A patent/AU2003230366A1/en not_active Abandoned
-
2004
- 2004-11-04 IL IL16503104A patent/IL165031A0/xx unknown
-
2009
- 2009-02-04 US US12/365,662 patent/US20100008892A1/en not_active Abandoned
-
2011
- 2011-09-01 HK HK11109240.6A patent/HK1154940A1/xx not_active IP Right Cessation
-
2012
- 2012-06-14 US US13/523,814 patent/US20120252034A1/en not_active Abandoned
-
2017
- 2017-05-31 US US15/610,321 patent/US20170363625A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20060234309A1 (en) | 2006-10-19 |
EP1507868B1 (de) | 2011-11-16 |
HK1154940A1 (en) | 2012-05-04 |
US20120252034A1 (en) | 2012-10-04 |
CA2484743A1 (en) | 2003-11-20 |
WO2003095668A1 (en) | 2003-11-20 |
US20170363625A1 (en) | 2017-12-21 |
US20100008892A1 (en) | 2010-01-14 |
MXPA04011071A (es) | 2005-07-14 |
EP2290368A1 (de) | 2011-03-02 |
KR20120004544A (ko) | 2012-01-12 |
NZ536339A (en) | 2006-04-28 |
EP1507868A4 (de) | 2005-11-30 |
PL373119A1 (en) | 2005-08-08 |
AU2003230366A1 (en) | 2003-11-11 |
JP2005524412A (ja) | 2005-08-18 |
IL165031A0 (en) | 2005-12-18 |
EP1507868A1 (de) | 2005-02-23 |
EP2290368B1 (de) | 2012-12-19 |
CN1659285A (zh) | 2005-08-24 |
BR0309850A (pt) | 2005-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1154940A1 (en) | Quality assays for antigen presenting cells | |
BRPI0412667A (pt) | sìntese regiosseletiva de cci - 779 | |
MA29528B1 (fr) | Agents de fixation | |
ATE483825T1 (de) | Zusammensetzungen für die identifizierung von adenoviren | |
CY1114441T1 (el) | Συνδετικες ενωσεις, ανοσογονικες ενωσεις και πεπτιδομιμητικα | |
AU2002230842A1 (en) | Optical methods and systems for tissue analysis | |
MX336807B (es) | Composiciones y metodos para producir una composicion. | |
WO2006026195A3 (en) | Methods for assessing a physiological state of a mammalian retina | |
WO2005065121A3 (en) | Methods and compositions for the production of monoclonal antibodies | |
CY1112511T1 (el) | Κρυσταλλικη στερεα βαση ρασαγιλινης (rasagiline) | |
ATE470857T1 (de) | Lipophile, farbstoffbasierte fret-assays für die clostridientoxinaktivität | |
WO2005051178A3 (en) | Marker for neuromyelitis optica | |
WO2007051169A3 (en) | Use of b cell expansion agents in generating antibodies | |
EP2112224A3 (de) | Entwicklung von neuem Genmaterial unter Verwendung von Segregaten transgener Kreuzungen | |
NO20030495D0 (no) | Peptider som presenteres av celler | |
ATE207614T1 (de) | Fluoreszenzkorrelationsspektroskopiemodul für ein mikroskop | |
DE60103428D1 (de) | Identifizierung von zellen während kinetischer versuchsreihen | |
UY28558A1 (es) | Proteína | |
BRPI0412699A (pt) | compostos e particulados hidrofóbicos e aplicações destes | |
BRPI0414365A (pt) | composições, reagentes e kits para, e métodos de diagnosticar, monitorar e tratar obesidade e/ou diabetes | |
DE602006004114D1 (de) | Befestigungselement für Rohre und Kabel | |
ECSP034743A (es) | Peptidos a partir del anticuerpo 16/61d para tratar lupus eritematoso sistemico | |
WO2005042721A3 (en) | A method for altering the gender ratio of offspring in mammals by manipulation of spermatozoa | |
BRPI0411134A (pt) | aparelho e método para produzir sorvete tradicional e partìculas combinadas | |
MXPA04004018A (es) | Metodos de separacion por exclusion para toxicidad de compuestos de prueba. |